- 081MarketSource · Fierce Healthcare
GE HealthCare to acquire imaging software provider Intelerad for $2.3B
GE HealthCare announced a $2.3 billion acquisition of Intelerad, a cloud-based imaging software provider serving radiology, cardiology, and clinical trial workflows. The deal expands GE HealthCare's outpatient imaging portfolio and complements its existing in-hospital imaging infrastructure. Intelerad's platform serves independent practices and healthcare networks with DICOM viewing, management, and AI-enabled analysis tools.
- 082MarketSource · Fierce Healthcare
Abbott dives into cancer diagnostics with $23B buyout of Exact Sciences
Abbott announced a $23 billion acquisition of Exact Sciences, the developer of Cologuard and blood-based cancer screening tests. The deal marks the largest diagnostics acquisition to date and significantly expands Abbott's oncology diagnostic portfolio, combining Exact Sciences' colorectal and multi-cancer detection platforms with Abbott's existing diagnostic infrastructure and distribution capabilities.
- 083MarketSource · Fierce Healthcare
Tempus claims AI pathology developer Paige in $81M deal
Tempus acquired AI pathology developer Paige for $81 million, gaining access to a dataset of nearly 7 million digitized pathology slides and associated clinical data from Memorial Sloan Kettering Cancer Center. The acquisition adds Paige's machine-learning capabilities in digital pathology to Tempus's oncology-focused platform.
- 084MarketSource · Fierce Healthcare
Philips to invest $150M in US manufacturing base, including ultrasound site expansion
Philips announced a $150 million investment in its U.S. manufacturing footprint, including expansion of a Pennsylvania facility dedicated to hospital ultrasound equipment production. The move reflects the company's strategy to strengthen domestic manufacturing capacity for imaging hardware.
- 085MarketSource · Fierce Healthcare
Ultromics nets $55M to boost its AI ultrasound software for detecting hidden heart failure
Ultromics secured $55 million in venture funding to scale its AI-driven ultrasound software platform for detecting occult heart failure. The funding will support commercial expansion of the company's diagnostic tools, which use machine learning to identify cardiac abnormalities from echocardiography images that may be missed by conventional analysis.